Country |
Date dd/mm/yyyy .............. |
Name of respondent(s) |
Position(s) |
................................ |
................................ |
................................ |
................................ |
| |
2003 |
|
1. NATIONAL MEDICINES (DRUG POLICY (NMP) |
|
1.1 Is there a National Medicines Policy (NMP) document? (See glossary for a definition of NMP.) If no, skip to 1.4. |
Yes/No/Don’t Know |
Is it an official or draft document? |
Official/Draft/Don’t Know |
What year was it last updated? |
Year _____ |
1.2 Is there an NMP implementation plan that sets activities, responsibilities, budgets, and timeline? |
Yes/No/Don’t Know |
If yes, when was it last updated? |
Year _____ |
1.3 Is the NMP integrated into a published/official national health policy/plan? If yes, when was it last updated? |
Yes/No/Don’t Know |
Year _____ |
1.4 Is there a national policy on traditional and complementary/ alternative medicine (TM/CAM) either as part of the medicine policy or health policy or as a separate document? (TM/CAM is defined in the glossary.) |
Yes/No/Don’t Know |
If yes, when was it last updated? |
Year _____ |
1.5 Has a national assessment/indicator study been conducted? If yes, what areas have been studied and when was the most recent study covering each area conducted? |
Yes/No/Don’t Know |
Overall pharmaceutical situation: |
Yes/No/Don’t Know |
Year _____ |
Rational use/prescription audit: |
Yes/No/Don’t Know |
Year _____ |
Access |
Yes/No/Don’t Know |
Year _____ |
2. LEGISLATION/REGULATION |
|
Is there a medicines law? If yes, when was it last updated? Which of the following areas are covered by medicines legislation and when was last updated? |
Yes/No/Don’t Know |
Year _____ |
Establishment of regulatory authority: |
Yes/No/Don’t Know |
Year _____ |
Marketing authorization of pharmaceuticals: |
Yes/No/Don’t Know |
Year _____ |
Manufacturing of medicines: |
Yes/No/Don’t Know |
Year _____ |
Distribution of medicines: |
Yes/No/Don’t Know |
Year _____ |
Promotion & advertising of medicines: |
Yes/No/Don’t Know |
Year _____ |
Importation of medicines: |
Yes/No/Don’t Know |
Year _____ |
Exportation of medicines: |
Yes/No/Don’t Know |
Year _____ |
Licensing & practice of prescribers: |
Yes/No/Don’t Know |
Year _____ |
Licensing & practice of pharmacy: |
Yes/No/Don’t Know |
Year _____ |
Herbal medicines (See glossary for definition): |
Yes/No/Don’t Know |
Year _____ |
Empowers inspectors to enter premises and collect samples and documentation: |
Yes/No/Don’t Know |
Year _____ |
Requires transparency, accountability and code of conduct in regulatory work: |
Yes/No/Don’t Know |
Year _____ |
2.2 System and operation of medicines registration: |
|
a) Is marketing authorisation required for medicines to be sold? If yes, how many medicinal products have been approved to be marketed? (express as number of dosage forms & strengths) |
Yes/No/Don’t Know Total______ |
Is marketing authorisation required for herbal medicines to be sold? If yes, how many herbal medicinal products have been approved to be marketed? (express as number of dosage forms & strengths) (See glossary for a definition of herbal medicines) |
Yes/No/Don’t Know Total______ |
b) Are there detailed written guidelines, including reference guidelines and criteria, for submitting applications for the registration of medicinal products? Are there guidelines covering the registration of herbal medicines? |
Yes/No/Don’t Know Yes/No/Don’t Know |
c) Is the WHO Certification Scheme certificate required as part of the marketing authorisation process? |
Yes/No/Don’t Know |
d) Is INN used in the registration of medicines? |
Yes/No/Don’t Know |
e) Is a list of all registered products publicly accessible? (Registered product is defined in the glossary.) |
Yes/No/Don’t Know |
2.3 Is there a computerised registration system that facilitates retrieval of information on registered products? (Registration system is defined in the glossary.) |
Yes/No/Don’t Know |
Is there a medicines regulatory authority website providing publicly accessible information on any of the following: legislation, regulatory procedures, prescribing information (such as indications, counter-indications, side effects, etc.), authorized companies, and/or approved medicines? |
Yes/No/Don’t Know |
2.4 Is licensing a requirement? (Licensing is defined in the glossary.) If yes, is it based on site inspection of: |
Yes/No/Don’t Know |
Manufacturers: |
Yes/No/Don’t Know |
Importers/wholesalers: |
Yes/No/Don’t Know |
Retail distributors/pharmacies: |
Yes/No/Don’t Know |
2.5 Are there written national guidelines/codes/checklists for the inspection of: |
|
Manufacturers: |
Yes/No/Don’t Know |
Importers/wholesalers: |
Yes/No/Don’t Know |
Retail distributors/pharmacies: |
Yes/No/Don’t Know |
2.6 Is prescribing by generic name obligatory in the: |
|
Public sector: |
Yes/No/Don’t Know |
Private sector: |
Yes/No/Don’t Know |
Is generic substitution permitted at: (Generic substitution is defined in the glossary.) |
|
Public pharmacies: |
Yes/No/Don’t Know |
Private pharmacies: |
Yes/No/Don’t Know |
2.7 Is promotion/advertisement of medicines reg |
|
Company self-regulation: |
Yes/No/Don’t Know |
Government agency or medicines regulatory authority: |
Yes/No/Don’t Know |
Are civil society/non-governmental organisations involved in review, assessment, or surveillance of promotion/ advertisement of medicines? |
Yes/No/Don’t Know |
Do regulations on promotion/advertisement of medicines include: (See glossary for the distinction between promotion and advertisement.) |
|
Published ethical criteria for medicines promotion: |
Yes/No/Don’t Know |
Pre-approval for promotional materials: |
Yes/No/Don’t Know |
Pre-approval for advertisement materials: |
Yes/No/Don’t Know |
Explicit prohibition on advertising prescription medicines: |
Yes/No/Don’t Know |
Detailed restrictions on advertising nonprescription medicines: |
Yes/No/Don’t Know |
2.8 Are adverse drug reactions (ADR) monitored? If yes, what is the total number of each of the following for the most recent year for which data is available? |
Yes/No/Don’t Know |
Total number of validated ADR reports received: |
__(Year ___) DK |
Total number of reporting physicians: |
__(Year ___) DK |
Total number of physicians in country: |
__(Year ___) DK |
Are ADR of herbal medicines monitored? |
Yes/No/Don’t Know |
3. QUALITY CONTROL OF PHARMACEUTICALS |
|
3.1 Testing of medicines samples collected last year for regulatory purposes (i.e. including drug registration and post-marketing surveillance, but excluding testing done in conjunction with procurement activities): |
Total number of samples |
|
Total number of samples collected: |
________ |
Don’t Know |
Total number of samples tested: |
________ |
Don’t Know |
Total number of samples that failed identity or assay: |
________ |
Don’t Know |
3.2 Where have the above samples (see 3.1) been tested: |
Percentage of total samples tested |
|
Government quality control laboratory: |
_______ % |
Don’t Know |
Local academic institutions: |
_______ % |
Don’t Know |
Quality control laboratory in another country: |
_______ % |
Don’t Know |
Private quality control laboratory: |
_______ % |
Don’t Know |
4. ESSENTIAL MEDICINES LIST (EML) |
|
|
4.1 Are there Essential Medicines Lists (EML)? (An Essential Medicines List is a government-approved selective list of medicines or national reimbursement list) |
|
Total number of medicines |
Year of last update |
National EML: |
Yes/No/DK |
_______ |
_______ |
State or provincial list: |
Yes/No/DK |
_______ |
_______ |
List for primary health care: |
Yes/No/DK |
_______ |
_______ |
4.2 Are EMLs being used in: |
|
Public sector procurement: |
Yes/No/Don’t Know |
Public insurance reimbursement: |
Yes/No/Don’t Know |
Private insurance reimbursement: |
Yes/No/Don’t Know |
4.3 Are local herbal medicines included on the national EML? |
Yes/No/Don’t Know |
5. MEDICINES SUPPLY SYSTEM |
|
5.1 Who is responsible for public sector drug procurement and distribution? What percentage of the total cost is each responsible for? |
Procurement |
Distribution |
Ministry/Department of Health: |
Yes/No/DK ___ % |
Yes/No/DK __ % |
Non-governmental organisation (NGO): |
Yes/No/DK ___ % |
Yes/No/DK __ % |
Private institution contracted by the government: |
Yes/No/DK ___ % |
Yes/No/DK __ % |
Individual health institutions: |
Yes/No/DK ___ % |
Yes/No/DK __ % |
5.2 Is government procurement limited to medicines on the EML? |
Yes/No/Don’t Know |
If no, is a percentage of the budget set aside for non-EML items? |
Yes/No/Don’t Know |
What is the percentage? |
_______ % |
5.3 Type of tender and percentage of the total cost for each: (Tender is the process by which competing bids are entered for a particular contract.) |
|
Percentage of total cost |
National competitive tender: |
Yes/No/DK |
_______ % |
International competitive tender: |
Yes/No/DK |
_______ % |
Negotiation/direct purchasing: |
Yes/No/DK |
_______ % |
5.4 Is drug registration a prerequisite for government purchases? |
|
6. MEDICINES FINANCING |
|
6.1 What is the total public or government budget for medicines in US$ for the most recent year for which data is available? |
$ _____, Year ____ |
| |
Public sector |
Private sector |
NGO |
6.2 Are there guidelines on medicines donations that cover the public sector, the private sector, or non-governmental organisations (NGO)? |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
6.3 Which medicines are free at primary public health facilities: |
|
All medicines are free of charge: |
Yes/No/Don’t Know |
Malaria medicines are free: |
Yes/No/Don’t Know |
Tuberculosis medicines are free: |
Yes/No/Don’t Know |
Sexually transmitted diseases medicines are free: |
Yes/No/Don’t Know |
HIV/AIDS-related medicines are free: |
Yes/No/Don’t Know |
Medicines are free to those who cannot afford them: |
Yes/No/Don’t Know |
Medicines are free for children under 5 years of age: |
Yes/No/Don’t Know |
Medicines are free for pregnant women: |
Yes/No/Don’t Know |
Medicines are free for elderly persons: |
Yes/No/Don’t Know |
No medicines are free of charge: |
(Don’t Know ) |
6.4 Which fees are charged in public health facilities: |
|
Registration/Consultation fees: |
Yes/No/Don’t Know |
Dispensing fees: |
Yes/No/Don’t Know |
Flat fees for medicines: |
Yes/No/Don’t Know |
Flat rate copayments: |
Yes/No/Don’t Know |
Percentage copayments: (Co-payments cover part of the cost of medicines, the other part being paid by an insurer or government.) |
Yes/No/Don’t Know |
6.5 Is revenue from fees or drug sales used to pay the salaries of public health personnel in the same facility? |
Always/Frequently/Occasionally/Never/DK |
6.6 Health insurance: (Health insurance is any prepayment scheme for health care costs additional to but excluding subsidies funded through the Ministry of Health budget.) |
Public |
Private |
What percentage of the population has health insurance? |
All/Some/None/DK |
All/Some/None/DK |
Are medicines covered by health insurance? |
All/Some/None/DK |
All/Some/None/DK |
Of the covered medicines, what percentage of the cost is covered: |
____ % |
____ % |
6.7 Is there a pricing policy on medicines that covers the public sector, the private sector, or non- governmental organisations? |
Public sector |
Private sector |
NGO |
If yes, does it apply to: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
All medicines, some or none: |
All/Some/None/DK |
All/Some/None/DK |
All/Some/None/DK |
Is maximum wholesale mark up established in laws/regulations: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
If yes, amount: |
____ % |
____ % |
____ % |
Maximum retail mark up established in laws/regulations: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
If yes, amount: |
____ % |
____ % |
____ % |
Duty on imported raw pharmaceutical materials: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Duty on imported finished pharmaceutical products: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
7. ACCESS TO ESSENTIAL MEDICINES |
|
7.1 In your opinion, what percentage of the population has regular access to essential medicines (i.e. minimum of 20 most essential medicines available and affordable at public and private facilities within a one-hour walking distance)? |
____ % |
7.2 What percentage of: |
Public health facility |
Private health facility |
Public or private retail drug outlet |
The population is within one-hour walking distance to: |
____ % |
____ % |
____ % |
Facilities have essential medicines available: |
____ % |
____ % |
____ % |
The population can afford essential medicines at: |
____ % |
____ % |
____ % |
8. PRODUCTION |
|
8.1 What is the medicines production capability in the country? |
|
Research and development of new active substances: |
Yes/No/Don’t Know |
Production of pharmaceutical active starting materials: |
Yes/No/Don’t Know |
Formulation from pharmaceutical starting materials: |
Yes/No/Don’t Know |
Repackaging of finished dosage forms: |
Yes/No/Don’t Know |
8.2 For each of the following types of local production, indicate number of factories and total annual sales in US$ for the most recent year for which data is available: |
Number of factories |
Sales in US$ |
Year |
Don’t know |
Starting materials: |
_ |
$ _ |
_ |
DK |
Finished products: |
_ |
$ _ |
_ |
DK |
Products containing active substances developed/marketed for the first time during the last 5 years: |
_ |
$ _ |
_ |
DK |
8.3 What is the total volume and US$ value of the medicines market? Generic medicines compose what percentage of market volume and value? |
Volume ____, Value $ ____ Volume ____%, Value ____% |
9. RATIONAL USE OF MEDICINES |
|
9.1 Are there standard treatment guidelines (STGs) produced by the health ministry/department for major conditions? (STGs are recommendations about how to treat a clinical condition.) |
|
Number of condition s/ diseases |
Year of publication or review |
National STG: |
Yes/No/DK |
____ |
____ |
STG for hospital level: |
Yes/No/DK |
____ |
____ |
STG for primary health care level: |
Yes/No/DK |
____ |
____ |
9.2 Is there a National Medicines Formulary manual? (A formulary manual contains summary drug information.) If yes, does it cover only medicines on the Essential Medicines List? |
Yes/No/Don’t Know Yes/No/Don’t Know |
What year was it last published/reviewed: |
Year ___ |
9.3 Are any of the following aspects of the essential medicines concept generally part of the basic curricula in most health training institutions/universities for: (Essential medicines are those that satisfy the priority health care needs of the population. See glossary for a definition of problem-based pharmaco-therapy.) |
Essential Medicines List |
Standard Treatment Guidelines |
Problem-based pharmaco-therapy |
Rational prescribing |
Doctors: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Nurses: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Pharmacists: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Pharmacy assistants: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Paramedical staff: |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
Yes/No/DK |
9.4 Are there independent publicly or non- commercially funded obligatory continuing education programs which include use of medicines for: |
|
Doctors: |
Yes/No/Don’t Know |
Nurses/midwives/paramedical staff: |
Yes/No/Don’t Know |
Pharmacists: |
Yes/No/Don’t Know |
Pharmacy aides/assistants: |
Yes/No/Don’t Know |
9.5 Is there a public or independently funded nationally accessible (e.g. by phone) medicines information centre or service co-ordinated by the Ministry of Health, academia, and/or a non-commercial non-governmental organisation that provides information on demand to: |
|
Prescribers: |
Yes/No/Don’t Know |
Dispensers: |
Yes/No/Don’t Know |
Consumers: |
Yes/No/Don’t Know |
9.6 Has there been any public education campaign concerning rational medicines use in the previous two years conducted by Ministry of Health/non-governmental organisation/academia on the following topics: |
|
Use of antibiotics: |
Yes/No/Don’t Know |
Use of injections: |
Yes/No/Don’t Know |
Other topics/issues: |
Yes/No/Don’t Know |
9.7 How often do the following personnel prescribe at the primary health care level in the public sector? |
|
Doctors: |
Always/Frequently/Occasionally/Never/DK |
Nurses/midwives/paramedical staff: |
Always/Frequently/Occasionally/Never/DK |
Pharmacists: |
Always/Frequently/Occasionally/Never/DK |
Pharmacy aides/assistants: |
Always/Frequently/Occasionally/Never/DK |
Personnel with less than one month formal health training: |
Always/Frequently/Occasionally/Never/DK |
9.8 Is there a government department with a specific mandate to promote the rational use of medicines and co-ordinate medicines use policies? |
Yes/No/Don’t Know |
9.9 What proportion of facilities have a drugs and therapeutics committee? (A drugs and therapeutics committee promotes the safe and effective use of medicines in the facility or area under its jurisdiction) |
|
Referral hospitals: |
All/Most/Half/Few/None/Don’t Know |
General hospitals: |
All/Most/Half/Few/None/Don’t Know |
Regions/provinces: |
All/Most/Half/Few/None/Don’t Know |
Is there a mandate for drugs and therapeutics committees in the national medicines policy? |
Yes/No/Don’t Know |
9.10 Is there a national strategy to contain antimicrobial resistance? |
Yes/No/Don’t Know |
Is there a national reference laboratory to coordinate epidemiological surveillance of antimicrobial resistance? |
Yes/No/Don’t Know |
Is there a funded national intersectoral task force to coordinate the implementation of interventions to promote appropriate use of antimicrobials and prevent the spread of infection? |
Yes/No/Don’t Know |
9.11 Are the following medicines sold over the counter without any prescription? |
|
Antibiotics: |
Always/Frequently/Occasionally/Never/DK |
Injections: |
Always/Frequently/Occasionally/Never/DK |
10. INTELLECTUAL PROPERTY RIGHTS PROTECTION AND MARKETING AUTHORIZATION |
|
10.1 Is patent protection legally provided for pharmaceutical products? |
|
If yes, indicate: |
Yes/No/Don’t Know |
Year introduced: |
____ |
Type: |
Process/Product/Both/Don’t Know |
Duration of patent validity: |
____ |
10.2 Which intellectual property right protection regime/activities are provided for traditional medical knowledge? |
|
Year introduced |
Duration of data protection |
TRIPS: |
Yes/No/DK |
____ |
____ |
Sui generis regimes: |
Yes/No/DK |
____ |
____ |
Digital library: |
Yes/No/DK |
____ |
____ |
National inventory of medicinal plants: |
Yes/No/DK |
____ |
____ |
Others: |
Yes/No/DK |
____ |
____ |
None: |
(DK ) |
|
|
10.3 TRIPS Agreement (Agreement on Trade Related Aspects of Intellectual Property Rights): |
a) Is your country a World Trade Organization Member? If no, skip to 10.4 |
Yes/No/Don’t Know |
b) Has national legislation been modified to implement the TRIPS Agreement? If yes, what year did it go into effect? |
Yes/No/Don’t Know Year |
c) Is your country availing itself of the transitional period provided by Article 65 of the TRIPS Agreement? |
Yes/No/Don’t Know |
d) If your country is a least-developing country (LDC), has it availed itself of the transitional period accorded to LDCs in Article 66 of the TRIPS Agreement? |
Yes/No/DK/Country not an LDC |
10.4 Have parallel importing provisions on pharmaceuticals been incorporated into national legislation? If yes, have these provisions been applied? |
Yes/No/DK/Currently being discussed Yes/No/DK/Currently being discussed |
10.5 Have compulsory licensing provisions for pharmaceuticals been incorporated into national legislation? If yes, under what conditions? |
Yes/No/DK/Currently being discussed |
National emergency: |
Yes/No/Don’t Know |
Public non-commercial use: |
Yes/No/Don’t Know |
Remedying anti-competitive practices: |
Yes/No/Don’t Know |
Other: |
Yes/No/Don’t Know |
10.6 Are generic pharmaceutical manufacturers allowed to use patented inventions for the purpose of obtaining marketing approval prior to patent expiration? |
Yes/No/DK/Currently being discussed |